Clinical Trials on Opioid Use Disorder, Mild in Hungary

Total 7 results

Braeburn Pharmaceuticals

Completed

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

Opioid Use Disorder

United States, United Kingdom, Taiwan, Hungary, Australia, Denmark, Germany, Sweden
Semmelweis University

Completed

Computer Games to Prevent Mild Cognitive Impairment and Dementia

Mild Cognitive Impairment

Hungary
Semmelweis University

Completed

Acute Oral Effects of Heated Tobacco Products

Nicotine Dependence, Cigarettes

Hungary
AstraZeneca

Completed

4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (ROBIN)

Mild to Moderate Alzheimer's Disease

Czech Republic, Hungary, Slovakia
AstraZeneca

Completed

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Opioid-Induced Constipation (OIC)

Croatia, Sweden, United States, Czech Republic, Spain, Hungary, United Kingdom, Belgium
Shionogi

Completed

Long Term Safety of Naldemedine

Opioid-induced Constipation

United States, Australia, Austria, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Poland, South Africa, Spain, Sweden, United Kingdom
FUJIFILM Toyama Chemical Co., Ltd.

Completed

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Mild Cognitive Impairment

Netherlands, United Kingdom, Ireland, Spain, Germany, Czechia, Hungary

3

Subscribe